1-5 of 5
H. Karel Nieuwenhuis
Close
Sort by
Journal Articles

A New Pathogenomic Mechanism In FPD/AML by a Constitutional T(16;21) Involving 16p13 ATF7IP2 and 21q22 RUNX1 Loci

Arjan Buijs, PhD, Saskia van der Crabben, MD, PhD, Bert van der Zwaag, PhD, Ellen van Binsbergen, MSc, Martin Poot, PhD, Okke de Weerdt, Marielle van Gijn, PhD, H. Karel Nieuwenhuis, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4851.
https://doi.org/10.1182/blood.V116.21.4851.4851
Published: 2010
Journal Articles

The Role of GBPIalpha in Phagocytosis of Platelets by Macrophages.

Bahram Alamdary Badlou, PhD, Gerit Spierenburg, Hans Ulricht, PhD, Hans Deckmyn, PhD, W. Martin Smid, MD, J.W.N. Akkerman, PhD, H. Karel Nieuwenhuis
Journal: Blood
Blood (2006) 108 (11): 3958.
https://doi.org/10.1182/blood.V108.11.3958.3958
Published: 2006
Journal Articles

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired α IIb β 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation

Ton Lisman, Sultana Moschatsis, Jelle Adelmeijer, H. Karel Nieuwenhuis, Philip G. De Groot
Journal: Blood
Blood (2003) 101 (5): 1864–1870.
https://doi.org/10.1182/blood-2002-09-2761
Published: 2003
Journal Articles

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A

Ton Lisman, Laurent O. Mosnier, Thierry Lambert, Evelien P. Mauser-Bunschoten, Joost C. M. Meijers, H. Karel Nieuwenhuis, Philip G. de Groot
Journal: Blood
Blood (2002) 99 (1): 175–179.
https://doi.org/10.1182/blood.V99.1.175
Published: 2002
Journal Articles

Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma

Leo F. Verdonck, Adriaan W. Dekker, Henk M. Lokhorst, Eefke J. Petersen, H. Karel Nieuwenhuis
Journal: Blood
Blood (1997) 90 (10): 4201–4205.
https://doi.org/10.1182/blood.V90.10.4201
Published: 1997